| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Actinic keratoses: non-invasive diagnosis for field cancerisation
|
Ulrich, M.
|
|
2007
|
156 |
s3 |
p. 13-17
|
artikel
|
| 2 |
Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification
|
Röwert-Huber, J.
|
|
2007
|
156 |
s3 |
p. 8-12
|
artikel
|
| 3 |
Apoptosis pathways as promising targets for skin cancer therapy
|
Eberle, J.
|
|
2007
|
156 |
s3 |
p. 18-24
|
artikel
|
| 4 |
Differentiation between actinic keratoses and disseminated superficial actinic porokeratoses with reflectance confocal microscopy
|
Ulrich, M.
|
|
2007
|
156 |
s3 |
p. 47-52
|
artikel
|
| 5 |
Does progression from actinic keratosis and Bowen's disease end with treatment: diclofenac 3% gel, an old drug in a new environment?
|
Patel, M. J.
|
|
2007
|
156 |
s3 |
p. 53-56
|
artikel
|
| 6 |
Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions
|
Trakatelli, M.
|
|
2007
|
156 |
s3 |
p. 1-7
|
artikel
|
| 7 |
Genetically determined susceptibility to COX-2 inhibitors – a report of exaggerated responders to diclofenac 3% gel in the treatment of actinic keratoses
|
Patel, M.J.
|
|
2007
|
156 |
s3 |
p. 57-61
|
artikel
|
| 8 |
Low prevalence of p53, p16INK4a and Ha-ras tumour-specific mutations in low-graded actinic keratosis
|
Nindl, I.
|
|
2007
|
156 |
s3 |
p. 34-39
|
artikel
|
| 9 |
Management of actinic cheilitis using diclofenac 3% gel: a report of six cases
|
Ulrich, C.
|
|
2007
|
156 |
s3 |
p. 43-46
|
artikel
|
| 10 |
The role of apoptosis in therapy and prophylaxis of epithelial tumours by nonsteroidal anti-inflammatory drugs (NSAIDs)
|
Fecker, L.F.
|
|
2007
|
156 |
s3 |
p. 25-33
|
artikel
|
| 11 |
Treatment of multiple actinic keratoses with topical diclofenac 3% gel in organ transplant recipients: a series of six cases
|
Ulrich, C.
|
|
2007
|
156 |
s3 |
p. 40-42
|
artikel
|
Tijdschrift beschrijving